跳至主要内容
临床试验/NCT07119593
NCT07119593进行中(未招募)不适用

Boosting Myocardial Preconditioning With High-Intensity Intradialytic Exercise: A Preliminary Study

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2025年9月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
15
试验地点
1
主要终点
Change in the number of left ventricular segments undergoing a greater than 20% reduction in longitudinal strain as detected by echocardiogram.

研究概览

简要总结

Patients receiving regular hemodialysis (HD) treatments are at a higher risk of cardiovascular events and death as HD can cause a decrease in the pumping of the heart during treatment called 'stunning'. Intradialytic exercise has emerged as a safe and effective non-drug approach to improve cardiovascular health and is now recommended for patients undergoing HD. It is currently advised that HD patients engage in at least 30 minutes of moderate to vigorous exercise three times per week. This study will evaluate the impact of exercise intensity in the HD population and determine if high impact exercise can offer better protection to the heart against HD-induced myocardial stunning.

详细描述

This will be the first randomized, cross-controlled trial evaluating the impact of exercise intensity in the HD population. If the efficacy of cardiovascular protection is proven, it could be developed as a therapeutic option in the dialysis population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Must be on chronic hemodialysis for at least 3 months
  • •Age ≥ 18 years of age
  • •Willing and able to provide informed consent

排除标准

  • •Regular vigorous exercise outside hemodialysis
  • •> 79 years of age
  • •Intradialytic exercise in the past 3 months
  • •Poor echogenicity
  • •Acute coronary syndrome in the past 3 months
  • •Unstable arrhythmia/angina
  • •Shortness of breath at rest or with minimal activity
  • •Symptomatic hypoglycemia (>2x/week in the week prior to enrolment)
  • •Symptomatic peripheral arterial disease
  • •Unable or deemed unsafe to exercise for any reason
  • •Severe musculoskeletal or orthopedic conditions
  • •Aortic stenosis
  • •Hypertrophic cardiopathy
  • •Severe pulmonary hypertension
  • •Symptomatic hypertension

研究组 & 干预措施

Randomization Order 1

Other

Participants will be randomized into one of the three conditions indicating the order in which they will receive the exercise intervention. Randomization Order 1 will receive control (no exercise) week one. Week 2 the participant will have a moderate intensity exercise treatment and week three the participant will have a high intensity exercise treatment. All sessions (i.e. HD-Cont, HD-Mod and HD-High) will be performed on one of the patient's three days of weekly dialysis. Each patient will consistently perform all sessions on the same day of dialysis throughout the study. The three sessions will be separate by at least one week to avoid potential carryover effects.

干预措施: Intradialytic Cycling (Other)

Randomization Order 2

Experimental

Participants will be randomized into one of the three conditions indicating the order in which they will receive the exercise intervention. Randomization Order 2 will receive moderate intensity exercise week one. Week 2 the participant will have high intensity exercise and week three the participant will have control (no exercise). All sessions (i.e. HD-Cont, HD-Mod and HD-High) will be performed on one of the patient's three days of weekly dialysis. Each patient will consistently perform all sessions on the same day of dialysis throughout the study. The three sessions will be separate by at least one week to avoid potential carryover effects.

干预措施: Intradialytic Cycling (Other)

Randomization 3

Experimental

Participants will be randomized into one of the three conditions indicating the order in which they will receive the exercise intervention. Randomization Order 3 will receive high intensity exercise week one. Week 2 the participant will have control (no exercise) and week three the participant will have a moderate intensity exercise treatment. All sessions (i.e. HD-Cont, HD-Mod and HD-High) will be performed on one of the patient's three days of weekly dialysis. Each patient will consistently perform all sessions on the same day of dialysis throughout the study. The three sessions will be separate by at least one week to avoid potential carryover effects.

干预措施: Intradialytic Cycling (Other)

结局指标

主要结局

Change in the number of left ventricular segments undergoing a greater than 20% reduction in longitudinal strain as detected by echocardiogram.

时间窗: Week 1 to Week 3

An echocardiogram will be completed pre-hemodialysis (HD) treatment and at peak hemodynamic stress (30 minutes before the end of HD treatment) at each of the study sessions. Images will be captured in the left lateral position and standard apical 4, and 2 chamber views will be recorded for analysis using automated speckle-training software. (EchoPac, GE Healthcare)

次要结局

  • Evaluate whether the increase in exercise intensity leads to a differential modulation of potential cardioprotective mechanisms, by evaluating their effects on hemodynamic responses (Blood Pressure)(Week 1 to week 3)
  • Evaluate whether the increase in exercise intensity leads to a differential modulation of potential cardioprotective mechanisms, by evaluating their effects on hemodynamic responses (Finapres)(Week 1 to Week 3)
  • Evaluate potential targets of exercise induced cardio protection by evaluating their effects on endothelial function.(Week 1 to Week 3)
  • Evaluate whether the increase in exercise intensity leads to a differential modulation of potential cardioprotective mechanisms, by evaluating their effects on hemodynamic responses (CV Insight Monitoring)(Week 1 to Week 3)
  • Evaluate whether the increase in exercise intensity leads to a differential modulation of potential cardioprotective mechanisms, focusing on blood markers.(Week 1 to Week 3)

研究者

发起方
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chris McIntyre

Nephrologist

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

研究点 (1)

Loading locations...

相似试验